Nippon India Pharma Fund-Growth Plan-Growth Option

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 575.6506 ↓ -0.93%
[as on 1 September, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option and its peers as on 1 September, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund-Growth Plan-Growth Option 13.05% -0.93% 0.45% 1.04% 8.84% 13.06% 18.66% 12.83% 22.25% 14.9%
Nippon India Banking & Financial Services Fund-Growth Plan-Growth Option -2.79% -1.47% -1.33% 0.11% 5.3% 6.13% 12.05% 12.73% 14.12% 12.28%
Nippon India Power & Infra Fund-Growth Plan -Growth Option 9.47% -0.37% -1.61% -0.04% 1.17% 12.47% 18.97% 20.73% 23.16% 16.98%
DSP Healthcare Fund - Regular Plan - Growth 17.44% -0.23% 0.67% 4.43% 13.67% 17.85% 21.37% 14.16% 24.37%-
DSP Banking & Financial Services Fund - Regular - Growth 5.9% -1.55% -0.7% 1.61% 10.19% 17.47%----
BANDHAN Infrastructure Fund - Regular Plan - Growth -0.2% -0.37% -2.33% -2.44% -0.12% -1.8% 14.71% 15.4% 20.27% 14.71%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -10.27% 7.14% 3.79% 2.14% 67.04% 22.66% -10% 40.12% 34.25% -3.81%

Discrete returns (monthly)

MonthNov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026
Returns 0.82% -1.31% -4.73% 5.23% -4.93% 5.96% 2.29% 5.39% 2.64% 1.99%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.53% 5.3%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
97.32% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 2.68%

Equity

NameSymbol / ISINSectorWeight %Other links
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.31%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology7.25%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.52%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology6.03%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.30%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.01%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology3.74%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.62%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.41%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing2.69%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.66%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.57%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.51%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.42%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.24%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology2.16%
Piramal Pharma LimitedPPLPHARMA (INE0DK501011)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.05%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.01%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.80%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.65%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.58%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology1.54%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.46%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.37%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology1.07%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.06%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.06%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology1.00%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.92%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.92%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.55%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.43%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.17%
Portfolio data is as on date 31 July, 2026

NAV history

Nippon India Pharma Fund-Growth Plan-Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
1 September, 2026575.6506 -0.93%
31 August, 2026581.0417 0.6%
28 August, 2026577.5836 0.19%
27 August, 2026576.4650 0.13%
26 August, 2026575.7105 0.46%
25 August, 2026573.0950 0.45%
24 August, 2026570.5332 -0.19%
21 August, 2026571.6444 0.09%
20 August, 2026571.1213 0.12%
19 August, 2026570.4646 -0.28%
18 August, 2026572.0845 0.28%
17 August, 2026570.4978 -0.46%
14 August, 2026573.1527 -0.22%
13 August, 2026574.4426 -0.22%
12 August, 2026575.7139 -0.02%
11 August, 2026575.8043 0.75%
10 August, 2026571.5271 0.09%
7 August, 2026571.0216 -0.02%
6 August, 2026571.1143 0.08%
5 August, 2026570.6777 -0.21%
4 August, 2026571.8633 -0.13%
3 August, 2026572.6344 0.52%
31 July, 2026569.6988 -0.19%
30 July, 2026570.8114 -0.08%
29 July, 2026571.2438 1.19%
28 July, 2026564.4981 0.11%
27 July, 2026563.8608 1.39%
24 July, 2026556.1074 -0.22%
23 July, 2026557.3415 -0.39%
22 July, 2026559.5402

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The latest NAV of Nippon India Pharma Fund-Growth Plan-Growth Option is 575.6506 as on 1 September, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.05% as on 1 September, 2026.
  • What are 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 1 year returns of Nippon India Pharma Fund-Growth Plan-Growth Option are 13.06% as on 1 September, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 18.66% as on 1 September, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.83% as on 1 September, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund-Growth Plan-Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund-Growth Plan-Growth Option are 12.83% as on 1 September, 2026.
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Nippon India Pharma Fund-Growth Plan-Growth Option?
    Nippon India Pharma Fund-Growth Plan-Growth Option is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.